Enzatamide plus Lutetium-PSMA as neoadjuvant therapy preceding radical prostatectomy for high risk localized/locally advanced prostate cancer: a Phase I/Ib trial
-
Enrollment
This study is not currently enrolling. -
Associated Conditions
-
Research Area
Clinical Cancer Research -
Sponsor
AdventHealth CFD